Dr. Donald Mattison, RSI’s Senior Vice-President and Chief Medical Officer, has accepted an appointment as a University of South Carolina Health Sciences Distinguished Professor in the in the Arnold School of Public Health (ASPH). The appointment noted that Dr. Mattison’s broad and deep career experience as a researcher and educator is impressive and valuable to USC. Dr Mattison’s academic home within ASPH will be in the Department of Epidemiology and Biostatistics. Dr Mattison anticipates continuing research on structure activity relationships in reproductive and developmental toxicology, drug and vaccine efficacy and safety, as well as other work with RSI.
The entire RSI family congratulates Dr. Mattison for his appointment.
Read Dr. Mattison’s bio here.
Posted in RSI News
More RSI News
Quinolones and risk of acute liver failure
Quinolones, are a class of widely used and popular powerful antibiotics with broad coverage. RSI investigators, Mohamed Taher, Franco Momoli, Donald Mattison and Daniel Krewski,…
Read News ItemRSI launches Global Risk Census
Risk Sciences International has launched The Global Risk Census. The goal of the Census is to provide insights into important risks that need to be…
Read News ItemUS FDA FAERS and quinolones
Some case reports on Quinolones, a potent and globally popular group of antibiotics that are used to treat a wide range of infections, have raised…
Read News ItemAdvancing Toxicity Testing webinar
The Center for Alternatives to Animal Testing and the Animal-Free Safety Assessment recently held their annual meeting on advancing toxicity testing in the 21st century…
Read News Item